As of today (2024-04-20), Assertio Holdings's share price is $0.773.
Assertio Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.80. Hence, Assertio Holdings's Price-to-Operating-Cash-Flow Ratio for today is 0.96.
The historical rank and industry rank for Assertio Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:
ASRT'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.49 Med: 5.73 Max: 272.36
Current: 0.97
During the past 13 years, Assertio Holdings's highest Price-to-Operating-Cash-Flow Ratio was 272.36. The lowest was 0.49. And the median was 5.73.
Assertio Holdings's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.06.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.80.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Assertio Holdings was -51.50% per year.
During the past 13 years, Assertio Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 146.30% per year. The lowest was -85.10% per year. And the median was -18.95% per year.
Assertio Holdings Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Assertio Holdings's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Assertio Holdings Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
0.98 |
- |
17.03 |
2.99 |
1.53 |
|
Assertio Holdings Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.99 |
4.83 |
4.23 |
2.25 |
1.53 |
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Assertio Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Assertio Holdings Price-to-Operating-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, Assertio Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Assertio Holdings's Price-to-Operating-Cash-Flow falls into.
Assertio Holdings Price-to-Operating-Cash-Flow Calculation
Assertio Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.773 | / | 0.802 |
| = | 0.96 |
Assertio Holdings's Share Price of today is $0.773.
Assertio Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Assertio Holdings (Assertio Holdings) Business Description
Traded in Other Exchanges
N/A
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Executives
| Daniel A. Peisert |
director, officer: President & CEO |
C/O ASSERTIO THERAPEUTICS, INC., 100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045 |
| Paul Schwichtenberg |
officer: SVP and CFO |
100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045 |
| Ajay Patel |
officer: SVP and CAO |
100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045 |
| Sam Schlessinger |
officer: SVP, General Counsel |
100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FORREST IL 60045 |
| William Mckee |
director |
|
| Jeff L Vacirca |
director |
4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121 |
| Heather L Mason |
director |
100 SOUTH SAUNDERS ROAD, SUITE 300, LAKE FOREST IL 60045 |
| James L Tyree |
director |
100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064-6400 |
| Crg Partners Iii - Parallel Fund (a) L.p. |
10 percent owner |
C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002 |
| Mark Strobeck |
officer: EVP & Chief Operating Officer |
460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087 |
| Crg Partners Iii L.p. |
10 percent owner |
1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002 |
| Cr Group L.p. |
10 percent owner |
1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002 |
| Andrea Heslin Smiley |
director |
600 LEE ROAD, SUITE 100, WAYNE PA 19087 |
| Megan C. Timmins |
officer: SVP, Gen Csl & Sec |
600 LEE ROAD, SUITE 100, WAYNE PA 19087 |
| Crg Partners Iii - Parallel Fund B (cayman) L.p. |
10 percent owner |
1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002 |
Assertio Holdings (Assertio Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASRT has been successfully added to your